Would also be positive to read something concrete around the Outlook. While in the past they announced targets, this years outlook purposefully avoids setting a line in the sand. How are shareholders meant to have any confidence in the company?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025